An Emerging Market Growth Story

Published in Company Comment on 30 June 2010

SSL is holding up well and looks set to prosper from new markets.

In uncertain and volatile markets, it makes sense to find stocks with earnings prospects that are relatively secure and unaffected by the economic cycle. 

As markets get sold off aggressively, individual stock correlations tend to go up. In other words, everything gets sold off indiscriminately.

This can create buying opportunities but, you need to be confident about the prospects for its earnings. There is no point buying a stock that has been sold off, only to find out later that the market was right!

One stock that I think fits the bill is SSL International (LSE: SSL) and, I would look at SSL in order to trade in and out of, during periods of market volatility.

What does it do?

SSL has two core brands , Durex and Scholl, which make up the bulk of their sales. Condoms and feet care are relatively recession proof industries.

During any downturn, there may be some trading-down effect whereby consumers buy less of the premium Durex products in favour of cheaper products. However, this hasn't proved significant in recent history and there is another growth driver here which actually involves consumers trading-up. I'm referring to their aggressive expansion into emerging markets. This is attractive due to higher economic growth rates in these countries.

Furthermore, as Russian/Chinese etc consumers get richer and more discerning, they may well aspire to using Western products with a strong brand identity, rather than the local alternative. 

To learn more about the business I would strongly recommend having a listen to the latest webcast on its website, which also includes a Q&A session. Why don't more companies do this?

A well run business

Clearly, SSL is planning on having good growth prospects because it recently restated its target "of growing EPS by 50% in the three years to March 2012". 

SSL looks well set to easily achieve this, if you believe the consensus forecasts. I reckon SSL is a very well run business and has executed its plans well over the last few years. 

Here are some key revenue and profitability metrics...

Year to 31 March20062007200820092010
Revenue (£m)451480534642804
EPS12.8p17.1p20.6p28p33.6p
EPS growth20%34%20%36%20%

Figures exclude one-off items.

Gross margins have been around 60% for all five years shown above, peaking at 62.2% last year. Revenue growth has been good as well, although £132m of the increase between 2009 and 2010 was due to emerging market acquisitions (Russia & Ukraine). Underlying growth was a much more sedate 1.8%, but this must be seen in the context of a depressed economic environment.

SSL coped with the downturn rather well and continued to generate good cash flow and improve its operational metrics:

Year to 31 March20062007200820092010
Net profit (£m)26.033.841.355.585.3
Working capital / sales26.7%23.9%22.2%20%17.9%
Net cash from
operating activities (£m)
11.434.330.276.2101.6
Free cash flow2.925.92145.487.1
Free cash flow yield0.2%1.5%1.2%2.7%5.1%
Free cash flow / net profit11%77%51%82%102%

For the above table, I used a share price of 800p and a market cap of £1.7bn. 

This table shows us that working capital requirements have fallen as a percentage of sales. This has caused the increase in profits to drop increasingly into free cash flow generation. This is impressive, given their continued capital investment in expanding manufacturing in emerging markets. 

Going forward consensus forecasts have EPS growth at 21% and 16% over the next two years, based upon pre-tax profits growth of 12% and 8.4%. 

SSL is not superficially cheap, but investors should be willing to pay a premium for relatively secure growth in this uncertain environment. Longer term its prospects look positive and it offers the opportunity of capturing emerging market growth trends. In my view, that makes it the kind of stock to pick up on any short-term market weakness.

More on the markets:

Share & subscribe

Comments

The opinions expressed here are those of the individual writers and are not representative of The Motley Fool. If you spot any comments that are unsuitable hit the flag to alert our moderators.

nookie1 01 Jul 2010 , 6:49am

Exactly my thoughts on SSL, recession proof products with a booming sales growth in the durex range.

Not only that SSL are on the cusp of securing the CE mark for their CSD500 'viagra condom'. SSL see this as potentially their market leading product. We are alerady over 90 days into the CE mark procedure and confidence is very high that it will be awarded.

This will add significant revenue for SSL. What's more they have a 'viagra gel' in development which will be progressed following the issue of the CE mark for the condom.
The important issue here is that both due to topical application have turned prescription ED drugs into over the counter. They act in minutes and don't carry the side effects. Both are blockbuster products which if they come to market will transform SSL.

Both of theses products come from Futura Medical (FUM). A small bio company that has an innovative gel called dernasys. This gel has indicated that it is outperforming the best products out there by a considerable margin, turning prescription oral drugs into effective direct application non prescription drugs.
They have just secured a partnership with GSK for their pain relief gel.
Numerous interested parties are in dicscussion for their PE gel. (Ready to market in the US).
The CE mark news is hugely pivotal for FUM and will transform the company overnight. That news is due right now. Currently about 42p having increased near 100% over the last year. It should quickly double or treble from that if the CE mark is awarded. Following news of a positive opinion by the regulatory body on the active ingredients of the condom it increased by over 175% in the following days.
It has been a long wait over many years but the fun and games are about to begin. Good luck SSL and FUM. people and investors will be kicking themselves that they didn't spot this.

LevelHeaded 01 Jul 2010 , 8:27am

Have looked into Futura Medical (FUM). I have to say I'm amazed at the potential here.

I think your right on CE-MARK news the effect on Futura'a share price will be massive

Join the conversation

Please take note - some tags have changed.

Line breaks are converted automatically.

You may use the following tags in your post: [b]bolded text[/b], [i]italicised text[/i]. All other tags will be removed from your post.

If you want to add a link, please ensure you type it as http://www.fool.co.uk as opposed to www.fool.co.uk.

Hello stranger

To add your own comment, please login.

Not yet registered? Register now.